Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-24-072875

Options or other derivatives

  • Director acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Chanan-Khan Asher Director 2024-06-14 Grant or award · Stock option (right to buy) +60,000 60,000 D
Loading xslF345X05/tm2417520-1_4seq1.xml…